SCHEMBL23310408

SCHEMBL23310408

Cc1cc(-c2ncnc3ccccc23)ccc1F

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K4 O95819 3/20 0.59
▸ CLK4 Q9HAZ1 3/20 0.59
▸ AURKA O14965 1/20 0.59
▸ DAPK3 O43293 1/20 0.59
▸ JAK2 O60674 1/20 0.59
▸ PRKD3 O94806 1/20 0.59
▸ PAK4 O96013 1/20 0.59
▸ NTRK1 P04629 1/20 0.59
▸ CSF1R P07333 1/20 0.59
▸ RET P07949 1/20 0.59
▸ IGF1R P08069 1/20 0.59
▸ MET P08581 1/20 0.59
▸ PIM1 P11309 1/20 0.59
▸ FGFR1 P11362 1/20 0.59
▸ PRKACA P17612 1/20 0.59
▸ FLT1 P17948 1/20 0.59
▸ LTK P29376 1/20 0.59
▸ GRK5 P34947 1/20 0.59
▸ KDR P35968 1/20 0.59
▸ MAP2K2 P36507 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23426075 0.83 PIM1 (0.58) MAP4K4CLK4AURKADAPK3JAK2
SCHEMBL30719601 0.81 ADORA2A (0.57) MAP4K4CLK4AURKADAPK3JAK2
SCHEMBL23496977 0.81 ADORA2A (0.57) MAP4K4CLK4AURKADAPK3JAK2
SCHEMBL29986591 0.78 ADORA2A (0.72) MAP4K4ADORA2AGRM4KITPIK3CD
SCHEMBL29986490 0.78 ADORA2A (0.72) METKDRADORA2ACAMKK1CAMKK2
SCHEMBL17666810 0.78 ADORA2A (0.72) MAP4K4ADORA2AGRM4KITPIK3CD
SCHEMBL23259465 0.78 ADORA2A (0.67) MAP4K4CLK4DAPK3PIM1PRKACA
SCHEMBL12357140 0.78 ADORA2A (0.72) METKDRADORA2ACAMKK1CAMKK2
SCHEMBL29987357 0.78 ADORA2A (0.66) MAP4K4CLK4METKDRADORA2A
SCHEMBL28872931 0.78 ADORA2A (0.66) MAP4K4METKDRADORA2ACAMKK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210122774-A1 ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210122774-A1 ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND L1CAM, NOM1, MSL1 MAP4K4 3786/4885CLK4 1813/4885AURKA 1452/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback